Insider Trading April 21, 2026 05:22 PM

Covenant Logistics CFO Sells $688k in Class A Shares Under 10b5-1 Plan

Transaction occurs as CVLG stock trades near 52-week high amid mixed Q4 2025 results and planned insider sales

By Maya Rios CVLG
Covenant Logistics CFO Sells $688k in Class A Shares Under 10b5-1 Plan
CVLG

James S. Grant III, Covenant Logistics Group's executive vice president and chief financial officer, disposed of 22,388 Class A shares on April 20, 2026, in a transaction valued at $688,431 under a Rule 10b5-1 plan. The sale comes while the stock approaches its 52-week peak and follows the company's fourth-quarter 2025 financial report and announced insider share dispositions by the CEO and his spouse.

Key Points

  • Covenant Logistics CFO James S. Grant III sold 22,388 Class A shares on April 20, 2026, for $30.75 each, totaling $688,431; sale executed under a Rule 10b5-1 trading plan adopted November 21, 2025.
  • The stock trades close to its 52-week high of $31.36 after a 72% one-year gain; external analysis indicates CVLG appears overvalued with an earnings multiple of 165.
  • Company posted Q4 2025 revenue of $295.37 million (2.62% above expectations) but reported EPS of $0.31 versus an expected $0.35 (an 11.43% shortfall); declared a $0.07 quarterly cash dividend payable to holders of record on March 6, 2026.

James S. Grant III, who serves as Executive Vice President and Chief Financial Officer of Covenant Logistics Group, Inc. (NASDAQ: CVLG), sold 22,388 shares of the company Class A Common Stock on April 20, 2026. The shares were sold at $30.75 each, producing total proceeds of $688,431.

The transaction was carried out pursuant to a Rule 10b5-1 trading plan Mr. Grant adopted on November 21, 2025. After completing the April 20 sale, Mr. Grant directly holds 20,915 shares of Covenant Logistics Group Class A Common Stock.

Covenant Logistics shares have been trading near a 52-week high of $31.36, reflecting a 72% gain over the past year. Independent analysis cited in reports describes CVLG as appearing overvalued versus its Fair Value estimate, noting that the stock is trading at an elevated earnings multiple of 165. The same research channel also offers extended Pro Research Reports covering CVLG and more than 1,400 other U.S. equities.


These insider-sale details arrive in the context of Covenant Logistics fourth-quarter 2025 financial results, which showed mixed performance. The company reported revenue of $295.37 million for the quarter, a figure that exceeded expectations by 2.62%. At the same time, earnings per share fell short of estimates: Covenant reported EPS of $0.31 versus an expected $0.35, an 11.43% shortfall.

Alongside the quarterly results, Covenant Logistics announced a cash dividend of $0.07 per share for both Class A and Class B common stock. The dividend is payable to shareholders of record as of March 6, 2026.

In addition to Mr. Grant s planned sale under a 10b5-1 arrangement, Covenant Logistics disclosed that Chairman and Chief Executive Officer David Parker and his wife, Jacqueline Parker, intend to sell shares valued at approximately $15 million. Those planned disposals are to be executed through open market and charitable gift transactions and are not being conducted under a Rule 10b5-1 trading plan.

Taken together, the filings and quarterly figures provide a concentrated view of recent insider activity and company results: a CFO sale under a pre-established trading plan, executive-level share dispositions without such a plan, a dividend declaration, a revenue beat, and an EPS miss. Observers tracking valuation metrics will note the referenced earnings multiple of 165 and the characterization of CVLG as appearing overvalued relative to a stated Fair Value estimate.

Where the market places importance - whether on the near-term financial performance, dividend policy, insider sales mechanics, or valuation metrics - will shape investor interpretation of these developments for Covenant Logistics Group.

Risks

  • Insider selling activity at the executive level, including planned sales by the CEO and spouse valued at approximately $15 million, could affect investor sentiment - relevant to equity and capital markets.
  • Valuation concerns are highlighted by an elevated earnings multiple of 165 and an assessment that CVLG appears overvalued relative to its Fair Value estimate - relevant to equity valuation and investment decision-making.
  • Mixed quarterly results, with a revenue beat but an EPS miss, introduce near-term performance uncertainty that may influence market reaction - relevant to corporate earnings and trader responses.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026